Corona Viral vaccine: Where is your country and the rest of the world in vaccination?
Our survival depends on bringing people from all over the world under the Covid-19 vaccine.
But the whole process of delivering the vaccine is very
complicated. It involves complex scientific processes, multinational
corporations, many conflicting government promises, huge bureaucratic networks,
and various regulatory policies. As a result, it is not easy to determine when
and how the vaccine will be delivered to everyone around the world.
Agatha Demere, director of the Global Forecasting Unit at the
Economist Intelligence Unit (EIU), has done some of the most comprehensive
research on the subject.
The EIU has conducted research on the total number of
vaccines the world is able to produce to reach the reach of all people, as well
as the healthcare infrastructure in different countries. In addition, in this study, they have taken into account the population of a country and the
financial capacity of the countries concerned.
The picture that emerges naturally from the results of their
research is inequality in the ability of rich and poor countries. The United
States and Britain currently have the largest supply of ticks. Because they
have invested the most money in vaccine innovation, they have been able to take
the top spot in the list of vaccine recipients.
They are followed by some other rich countries like Canada
and the European Union.
Many low-income countries have not yet begun vaccination. But
some countries have surprisingly launched programs, especially those in the
middle ground. See below what stage of vaccination program in which countries
of the world.
Note: This information is updated regularly, but may not
contain the latest information from each country. The total number of vaccines
means the total dose is given, not the number of people. For this reason, the dose
may be more than 100 per 100 people.
Source: OWID, gov.uk Dashboard, ONS
Last updated: May 4, 2021 5:29 PM GMT +6
Canada came under fire late last year for buying five times
as many vaccines as it needed to vaccinate all Canadians. However, it is seen
that they did not write their names in the list of vaccinations on a priority
basis.
This is because Canada had a concern that if Donald Trump
were in power, the United States would impose a ban on exports, and out of that
concern Canada decided to invest in vaccine manufacturers in Europe. However,
their decision was not considered.
Factories in Europe are now scrambling to provide vaccines,
and it has recently been seen that the EU, not the US, is now threatening to
impose sanctions on exports.
"As long as there are not enough vaccines in The European market, large imports will be blocked for Canada," said Ms. Agath
Demare.
But some countries are doing much better than expected.
At the time of writing, Serbia was ranked eighth in the world
in terms of population. Serbia is the most vaccinated country in the EU. The
reason for their success is partly to start the vaccination program
efficiently.
However, they have also benefited from vaccine diplomacy.
Because Russia and China are competing for influence in Eastern Europe. Serbia
is one of the few countries where the Russian vaccine Sputnik V and the Chinese
vaccine Cynoform are already being used.
On paper, the Serbian people are being given the opportunity
to choose which vaccine they want to take - Pfizer, Sputnik, or Sinopharm. But
the reality is that most people are being given the cyanoform vaccine. China
wants to extend its influence in the country's market.
Countries that will give the first and second doses of
cyanoform to the public will also have to rely on China if they want to give
booster doses in the future.
You can read more:
All your questions and answers about the coronavirus vaccine?
How to register in the security app to get vaccinated in
Bangladesh?
How will the corona vaccine reach 700 million people around
the world?
The UAE is also more dependent on cyanoform vaccines. The
current vaccination process in the country is 60% dose of cyanoform vaccine.
The emirate is also working to set up a pharmaceutical factory to produce
cyanoform vaccines locally.
“China is building production facilities there and offering
to train workers, so China is working on a far-reaching plan there,” says Agatha
Demare. "As a result, it will be very complicated for the governments of
the recipient countries not to talk to China about anything in the
future."
However, being one of the world's superpowers does not mean
that your country's population will be the first to be vaccinated.
EIU research suggests that China and India, two of the
world's most powerful vaccine producers, will not be able to vaccinate their
populations in sufficient numbers before the end of 2022. Because the
population of the two countries is huge. As a result, the two countries need to
vaccinate so many people on the one hand and address the shortage of health
workers on the other.
Ginger Punawala is one of the creditors behind the success of
covid vaccine production in India. His company, Serum Institute of India, is
the largest vaccine manufacturer in the world.
However, in the middle of last year, his family members began
to think Mr. Punawala's head has gone bad. Without knowing whether the Covid-19 vaccine would be effective, he spent billions of dollars on his own speculation
about the vaccine's production.
In January, Covid's first vaccine, invented by Oxford and
AstraZeneca was commissioned by the Indian government. Now Mr. Punawala is
making 24 lakh doses of vaccine every day in his company.
The serum is one of the two major providers of vaccines for
India. Also, Serum is supplying its vaccines to Bangladesh, Brazil, Morocco, and South Africa.
"Now that we've created this vaccine, I think this
stress and the current head-scratching situation will come to an end," he
says. "But the real challenge is to try to keep everyone happy.
"I thought there would be many more vaccine
manufacturers to supply. But the sad thing right now is that in the first three
months of 2021, and probably in the second quarter, the supply will not
increase significantly."
He says it is not possible to increase ticker production
overnight.
"It takes time," he said. Punawala. "People
think the Serum Institute can show magic. Yes, we're good at what we do, but we
don't have the magic wand in our hands."
But he is now in a better position than others. Because in
March last year he built a new place and in August he started stocking chemical
and ticker glass vials there.
The amount of vaccine being produced can vary greatly during
the vaccine production process, and there can be a lot of noise at many stages
of the process.
"It's a science on the one hand and an artist on the
other," says Ms. Agath Demere.
Vaccine manufacturers that are now starting production will
take several months to develop their vaccines. And if a booster dose is needed
to deal with a new strain of the virus, it will have the same problem.
Mr. Punawala says he is committed to providing vaccines to
the people of India first. And then on his list is Africa, where his company
has promised to provide vaccines through a project called Kovacs.
Kovacs is an initiative led by the World Health Organization,
an alliance on vaccines, Gavi and the Center for Epidemic Preparedness, or SEP.
The aim is to reach every country in the world with the vaccine.
Countries that do not have the financial means will receive
free vaccines through a special fund. The rest will have to pay for the
vaccine.
But their theory is that if they do it through the Kovacs the group instead of bargaining, they will bargain to get a cheaper price for them
through negotiations, and countries will be able to buy vaccines at a better
price.
Cox plans to begin vaccination work in late February.
In the meantime, many countries have taken separate vaccines
on their own initiative - the Covax plan has suffered a setback as a result of
running the court.
Ginger Punawala says leaders in almost every country in
Africa has approached her to get vaccinated independently.
Last week, Uganda announced that it had agreed to purchase 16
million doses of the vaccine from the Serum Institute at a cost of 8 per dose.
Coax buys each dose for ড 4. So
Uganda is going to buy the vaccine with a lot more money.
The Serum Institute says they are in talks with Uganda, but The serum has denied any agreement.
Mr. With the approval of the World Health Organization in
Pune, his company will provide 200 million doses of AstraZeneca vaccine to
Kovacs. He has promised to supply another 900 million doses of vaccine to
Kovacs.
However, he did not confirm when it would be delivered.
He says he is committed to the project but admits they are
also facing some problems.
Kovacs is working with a number of vaccine manufacturers, he
says. They are asking for different prices for ticks and giving different
schedules for delivery.
So Agatha Demere and the Economist Intelligence Unit are not
optimistic that Kovacs will be able to achieve their price and supply targets.
Despite the plan, the EIU estimates that Kovacs will be able to vaccinate 20 to
26% of a country's population this year.
"Their initiative will change the situation a little
bit, it won't change the situation a lot," says Agatha Demere.
In her forecast for the Economist Intelligence Unit, Ms.
Demerre said that in some countries, the end of 2023 will be the end of the
vaccination program for all people, and in some countries, vaccination for all
may never end.
However, vaccination may not be necessary for all countries,
especially in countries where the majority of the population is young, and
where people are not getting very sick.
In countries where such a situation exists, there is, of
course, another aspect of risk. That is, if the virus gets a chance to spread,
it will change the character and reach other countries through humans. The process
of becoming resistant to the virus will continue.
However, not everything is negative. Vaccines are being
developed faster than ever before. But even then, vaccinating 800 million
people around the world is a huge challenge. Such a big challenge has never
come in the past.
Agatha Demer thinks governments need to be transparent.
People need to be told the truth about what is actually possible: "It
would be very difficult for any government to say, 'No - it will take us
several more years to achieve the goal of vaccinating people on a large scale.'
No government would want to say that. "
0 Comments